quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:04:06·1380d
NEWSRelease
Pluristem Therapeutics Inc. logo

UPDATE: Pluristem Reports Results From Its Phase III Study Did Not Meet The Primary Endpoint

PSTI· Pluristem Therapeutics Inc.
Health Care
Original source

Companies

  • PSTI
    Pluristem Therapeutics Inc.
    Health Care

Related

  • PR783d
    Independence Realty Trust Appoints Craig Macnab to its Board of Directors
  • SEC1185d
    Pluristem Therapeutics Inc. filed SEC Form 8-K: Other Events
  • 13D/G1205d
    SEC Form SC 13D filed by Pluristem Therapeutics Inc.
  • SEC1210d
    SEC Form D filed by Pluristem Therapeutics Inc.
  • SEC1212d
    Pluristem Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • INSIDER1218d
    SEC Form 4: Yanay Yaky was granted 334,821 shares, increasing direct ownership by 23% to 1,760,125 units
  • INSIDER1218d
    SEC Form 4: Aberman Zami sold $1,940 worth of shares (2,000 units at $0.97), decreasing direct ownership by 0.13% to 1,491,973 units
  • SEC1221d
    Pluristem Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022